May 2018 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, dated 3 November 2016 and the 2017/18 Invitation to Tender, dated 2 November 2017.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand (http://www.pgnz.org.nz/about-us-1/pharmacode(external link)) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines (http://www.nzulm.org.nz/sponsors(external link)). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2016/17 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2020

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

1. Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Pack Price Hospital Supply
Brand (Supplier)
DVLimit Listing date Hospital Supply Status date
Granisetron Inj 1 mg per ml, 3 ml ampoule, 1 ampoule $0.40 Deva
(Deva Holdings)
1% 1 September 2018 1 November 2018

2017/18 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2021

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

2. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply date
Candesartan cilexetil* Tab 4 mg, 90 tablet bottle pack $2.50 $1.90 Candestar
(Mylan)
1 July 2018 1 October 2018
Candesartan cilexetil* Tab 8 mg, 90 tablet bottle pack $3.68 $2.28 Candestar
(Mylan)
1 July 2018 1 October 2018
Candesartan cilexetil* Tab 16 mg, 90 tablet bottle pack $6.12 $3.67 Candestar
(Mylan)
1 July 2018 1 October 2018
Candesartan cilexetil* Tab 32 mg, 90 tablet bottle pack $10.66 $6.39 Candestar
(Mylan)
1 July 2018 1 October 2018
Ciclopirox olamine Nail-soln 8%, 7 ml bottle OP $6.50 $5.72 Apo-Ciclopirox
(Apotex)
1 July 2018 1 October 2018
Heparin sodium Inj 5,000 iu per ml, 5 ml ampoule, 50 plastic ampoules $341.89 $203.68 Pfizer
(Pfizer New Zealand Ltd)
1 September 2018 1 December 2018
Oil in water emulsion Crm, 500 g tub $2.25 $2.19 O/W Fatty Emulsion Cream
(Boucher and Muir (NZ) Limited)
1 November 2018 1 February 2019
*Special Authority restriction applying to candesartan cilexetil will be removed from 1 July 2018

3. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Heparin sodium Inj 1,000 iu per ml, 5 ml ampoule, 50 plastic ampoules $99.50 $58.57 Pfizer
(Pfizer New Zealand Ltd)
1 September 2018 1 November 2018 1 February 2019 Hospira
(Pfizer New Zealand Ltd)10 inj and 50 inj packs
Ibuprofen Oral liq 20 mg per ml, 200 ml bottle $2.39 $1.88 Ethics
(Multichem New Zealand Ltd)
1 March 2019 1 May 2019 1 August 2019 Fenpaed
(AFT)
Metformin hydrochloride Tab immediate-release 500 mg, 1,000 tablet bottle pack $9.59 $8.63 Apotex
(Apotex NZ Ltd)
1 December 2018 1 February 2019 1 May 2019 Metchek
(API)
Metformin hydrochloride Tab immediate-release 850 mg, 500 tablet bottle pack $7.82 $7.04 Apotex
(Apotex NZ Ltd)
1 December 2018 1 February 2019 1 May 2019 Metformin Mylan
(Mylan)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

CORRECTION to May 2018 tender notification: in bold and strikethrough

4. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current price New price Hospital Supply Brand (Supplier) DVLimit Listing date Hospital Supply Status date
Candesartan cilexetil* Tab 4 mg, 90 tablet bottle pack $2.50 $1.90 Candestar
(Mylan)
1% 1 July 2018 1 September 2018
Candesartan cilexetil* Tab 8 mg, 90 tablet bottle pack $3.68 $2.28 Candestar
(Mylan)
1% 1 July 2018 1 September 2018
Candesartan cilexetil* Tab 16 mg, 90 tablet bottle pack $6.12 $3.67 Candestar
(Mylan)
1% 1 July 2018 1 September 2018
Candesartan cilexetil* Tab 32 mg, 90 tablet bottle pack $10.66 $6.39 Candestar
(Mylan)
1% 1 July 2018 1 September 2018
Ciclopirox olamine Nail soln 8%, 7 ml bottle (OP) $6.50 $5.72 Apo-Ciclopirox
(Apotex)
1% 1 July 2018 1 September 2018
Heparin sodium Inj 1,000 iu per ml, 5 ml ampoule, 50 plastic ampoules $99.50 $58.57 Pfizer
(Pfizer New Zealand Ltd)
1% 1 September 2018 1 November 2018
Heparin sodium Inj 5,000 iu per ml, 5 ml ampoule, 50 plastic ampoules $341.89 $203.68 Pfizer
(Pfizer New Zealand Ltd)
1% 1 September 2018 1 November 2018
Oil in water emulsion Crm, 100 g tub $1.60 $1.44 healthE Fatty Cream
(Jaychem)
1% 1 October 2018 1 December 2018
Tropisetron Inj 1 mg per ml, 2 ml ampoule, 1 ampoule $8.95 $8.95 Tropisetron-AFT
(AFT)
1% 1 July 2018 1 September 2018
*Indication Restriction applying to candesartan cilexetil will be removed from 1 July 2018

5. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current price New price Hospital Supply Brand (Supplier) DVLimit Listing date Hospital Supply Status date Brand (Supplier) affected by delisting
Ibuprofen Oral liq 20 mg per ml, 200 ml bottle $2.39 $1.88 Ethics
(Multichem New Zealand Ltd)
1% 1 March 2019 1 May 2019 Fenpaed(AFT)
Metformin hydrochloride Tab immediate-release 500 mg, 1,000 tablet bottle pack $9.59 $8.63 Apotex
(Apotex NZ Ltd)
1% 1 December 2018 2019 1 February 2019 Metchek(API)
Metformin hydrochloride Tab immediate-release 850 mg, 500 tablet bottle pack $7.82 $7.04 Apotex
(Apotex NZ Ltd)
1% 1 December 2018 2019 1 February 2019 Metformin Mylan(Mylan)
Midazolam Inj 1 mg per ml, 5 ml ampoule, 10 glass ampoules $4.30 $2.98 Mylan Midazolam
(Mylan New Zealand Ltd)
1% 1 November 2018 1 January 2019 Midazolam-Claris(AFT)
Midazolam Inj 5 mg per ml, 3 ml ampoule, 5 glass ampoules $2.50 $2.36 Mylan Midazolam
(Mylan New Zealand Ltd)
1% 1 November 2018 1 January 2019 Midazolam-Claris(AFT)
Oil in water emulsion1 Crm, 500 g, tub $2.63 $2.19 O/W Fatty Emulsion Cream
(Boucher and Muir (NZ) Limited)
1% 1 November 2018 1 January 2019 healthE Fatty Cream(Jaychem)
Sodium chloride Inj 0.9%, 3 ml syringe, non-sterile pack, 480 prefilled syringes2 $10.65 per 30 $160.90 BD PosiFlush
(Becton Dickinson)
1% 1 July 2018 1 September 2018 BD PosiFlush(30 pack)
Sodium chloride Inj 0.9%, 5 ml syringe, non-sterile pack, 480 prefilled syringes2 $10.80 per 30 $162.91 BD PosiFlush
(Becton Dickinson)
1% 1 July 2018 1 September 2018 BD PosiFlush(30 pack)
Sodium chloride Inj 0.9%, 10 ml syringe, non-sterile pack, 480 prefilled syringes2 $11.25 per 30 $170.35 BD PosiFlush
(Becton Dickinson)
1% 1 July 2018 1 September 2018 BD PosiFlush(30 pack)
1Note: DV limit applies to pack size greater than 100 g.
2The pack size for BD PosiFlush sodium chloride syringes is 480 which is an outer carton containing 16 x 30 syringe shelf packs.

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2016/17 Invitation to Tender, dated 3 November 2016, and the 2017/18 Invitation to Tender, dated 2 November 2017:

2016/17 Invitation to Tender

Chemical Name Line Item Chemical Name Line Item
Tetracaine [amethocaine] hydrochloride Gel 4% Trimethoprim with sulphamethoxazole [Co-trimoxazole] Inj 16 mg with sulphamethoxazole 80 mg per ml, 5 ml

2017/18 Invitation to Tender

Chemical Name Line Item
Adefovir dipivoxil Tab 10 mg
Amoxicillin clavulanate Inj 500 mg with clavulanic acid 100 mg
Amoxicillin clavulanate Inj 1000 mg with clavulanic acid 200 mg
Beractant Inj 25 mg per ml, 8 ml
Calcium carbonate Tab eff 0.875 – 1.75 g (0.5 g – 1 g elemental)
Calcium carbonate Oral liq 250 mg per ml (100 mg elemental per ml)
Candesartan (current access) Tab 4 mg
Candesartan (current access) Tab 8 mg
Candesartan (current access) Tab 16 mg
Candesartan (current access) Tab 32 mg
Carmustine Inj 100 mg
Cidofovir Inj 75 mg per ml, 5 ml
Colestimethate Inj 150 mg
Dextrochlorpheniramine maleate Tab 2 mg
Dextrochlorpheniramine maleate Oral liq 2 mg per 5 ml
Econazole nitrate Crm 1%
Etidronate disodium Tab 200 mg
Etoposide Inj 20 mg per ml, 5 ml
Fexofenadine hydrochloride Tab 60 mg
Framycetin sulphate Ear/eye drops 0.5%
Gentamicin sulphate Inj 10 mg per ml
Glucose [dextrose] Gel 40%
Glyceryl trinitrate Inj 5 mg per ml, 10 ml
Hydrocortisone Oint 1% (pack size greater than 100 g)
Hydrocortisone Oint 1% (pack size 100 g or less)
Hydrocortisone Oral liq
Hydrocortisone Tab 1 mg
Intra-uterine device IUD 29.1 mm length x 23.2 mm width
Intra-uterine device IUD 33.6 mm length x 29.9 mm width
Intra-uterine device IUD 35.5 mm length x 19.6 mm width
Lodoxamide Eye drops 0.1%
Mefloquine hydrochloride Tab 250 mg
Metformin hydrochloride Tab immediate-release 1 g
Methadone hydrochloride Inj 10 mg per ml, 1 ml
Metronidazole Gel 0.75%
Metronidazole Oral liq benzoate 200 mg per 5 ml
Metronidazole Suppos 500 mcg
Metronidazole Tab 200 mg
Metronidazole Tab 400 mg
Noradrenaline Inj 0.06 mg per ml, 100 ml bag
Noradrenaline Inj 0.12 mg per ml, 100 ml bag
Noradrenaline Inj 0.16 mg per ml, 50 ml syringe
Phenytoin Inj 50 mg per ml, 2 ml
Phenytoin Inj 50 mg per ml, 5 ml
Poractant alfa Soln 120 mg per 1.5 ml vial
Poractant alfa Soln 240 mg per 3 ml vial
Potassium dihydrogen phosphate Inj 1 mmol per ml, 10 ml
Povidone iodine Skin preparation, povidone iodine 10% with 20% alcohol (pack size greater than 100 ml)
Ticarcillin with clavulanic acid Inj 3 g with clavulanic acid 0.1 mg vial
Tropisetron Inj 1 mg per ml, 5 ml
Zopiclone Tab 3.75

For products included in the 2015/16, 2016/17 and 2017/18 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.